Probuphine – formidable hurdles will severely limit adoption

The FDA recently approved Probuphine, an implantable form of buprenorphine, for longer term maintenance treatment to address opiate withdrawal and opiate craving post opiate detoxification. Addiction expert, Dr. Cidambi provides her take on Probuphine. Her view is that implementation is cumbersome and will likely limit the uptake of the medication.